Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $463.1 million.

  • Pediatrix Medical's Cash & Current Investments rose 11006.89% to $463.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $463.1 million, marking a year-over-year increase of 11006.89%. This contributed to the annual value of $348.5 million for FY2024, which is 9607.3% up from last year.
  • As of Q3 2025, Pediatrix Medical's Cash & Current Investments stood at $463.1 million, which was up 11006.89% from $348.3 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Cash & Current Investments registered a high of $487.1 million during Q4 2021, and its lowest value of $96.8 million during Q1 2022.
  • Moreover, its 5-year median value for Cash & Current Investments was $177.7 million (2023), whereas its average is $237.8 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 7884.18% in 2022, then surged by 16151.19% in 2025.
  • Pediatrix Medical's Cash & Current Investments (Quarter) stood at $487.1 million in 2021, then plummeted by 78.84% to $103.1 million in 2022, then skyrocketed by 72.46% to $177.7 million in 2023, then skyrocketed by 96.07% to $348.5 million in 2024, then surged by 32.88% to $463.1 million in 2025.
  • Its Cash & Current Investments was $463.1 million in Q3 2025, compared to $348.3 million in Q2 2025 and $219.2 million in Q1 2025.